Do not display

Listen: Cancer Survival Rates Up Among Californians

Overall, Californians are beating cancer for longer due to earlier detection and better treatment of the disease, a new study reveals. But the gains are not felt equally: Whites fare better than blacks, and younger patients better than older.

Podcast: KHN’s ‘What The Health?’ Opioids, EpiPens And Health Funding

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico discuss Senate action on health funding and opioid legislation, the state of the individual insurance market and consternation over expiration dates on EpiPens, the self-injected allergy remedy. Also, could an otter with asthma signal a potential public health crisis?

Podcast: KHN’s ‘What The Health?’ See You In Court!

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner talk about a spate of lawsuits involving the Affordable Care Act, as well as the latest in state and federal efforts regarding the Medicaid program for the poor.

Escucha: mientras las llamaradas persistan, la salud sufrirá

Más de una docena de grandes incendios continúan ardiendo en California, y las autoridades que monitorean la calidad del aire están advirtiendo a los grupos más sensibles —niños, adultos mayores y personas con enfermedades respiratorias— que tomen medidas para proteger su salud. La periodista de California Healthline, Ana Ibarra, estuvo al aire para hablar sobre los impactos en la salud de los devastadores incendios forestales.

Podcast: KHN’s ‘What The Health?’ Coming Soon: ‘Long-Term Short-Term’ Plans

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner talk about the latest Trump administration efforts to address high drug prices, what’s next for short-term health insurance plans and insider trading charges against a New York GOP congressman.

Listen: Inexpensive Nerve Drug Often Abused As Opioid Epidemic Grows

Gabapentin, a medication approved to help patients with nerve pain or epilepsy, is being abused by people addicted to opioids to help prolong their high or stave off withdrawal from other drugs. Kaiser Health News reporter Carmen Heredia Rodriguez talks about the problem during a wide-ranging health discussion on the NPR program “On Point.”

Watch: What You Should Know About The New Rule On Short-Term Health Plans

Under the Trump administration’s new rule, these plans can now last as long as 12 months — instead of the Obama-era 90-day limit — and be renewed for two additional years. Critics say these changes are part of another swipe at the Affordable Care Act.